About this document
Optimizing Early Triple-Negative Cancer Treatment by Isailop77 is a document available to read on EtoBox.
This review discusses the optimization of treatment for early-stage triple-negative breast cancer (TNBC), highlighting the importance of achieving a pathological complete response (pCR) for better prognosis. It emphasizes the potential for treatment de-escalation in low-risk TNBC patients and the incorporation of immunotherapy and targeted agents for high-risk cases. The authors advocate for a risk-adapted approach that considers biomarkers and treatment responses to improve patient outcomes and reduce toxi
- Author
- Isailop77
- Language
- EN